Entheon Biomedical Corp. announced that it has closed patient enrolment in its clinical research study EBIQ-101. The company announced the closing of patient enrolment in its EBIQ-101 Study being conducted at Heading Health.
Entheon expects to commence the process of concluding the study in cooperation with its vendors and partners in the coming weeks.